🔎 Trials Near Me

Home › Burkitt Lymphoma › Pennsylvania › Pittsburgh

Burkitt Lymphoma clinical trials in Pittsburgh, PA

6 studies for Burkitt Lymphoma are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RecruitingPhase 2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Ages 1 to 30 · All sexes · Updated Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RecruitingPhase 3
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

RecruitingPhase 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07069699

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

RecruitingPhase 2
  • AHN Cancer Institute - West Penn Hospital, Pittsburgh
Ages 18 to 79 · All sexes · Updated Jan 13, 2025 · NCT05281809

Burkitt Lymphoma trials in other cities

Other studies in Pittsburgh

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.